2024 to be a year of Gaganyaan, ISRO eyeing record 12-14 missions this year: S Somanath
Sriharikota/IBNS/UNI: Asserting that 2024 will be the year of Gaganyaan by conducting a series of tests ahead of the first manned mission next year, the Indian Space Research Organisation (ISRO) Monday said it is having a busy schedule with a record 12 to 14 missions planned this year.
Talking to reporters after the successful first-ever New Year's Day launch of the PSLV-C58/XPoSat mission from the SHAR Range here, ISRO Chairman S. Somanath said 2024 has been named as the year of Gaganyaan.
ISRO will be carrying out various tests this year before the first manned mission takes off next year, he added.
After the huge success of the First Test Vehicle Abort Mission-1 (TV-D1) to demonstrate the crew escape system last year which marked the first major step to realise the Human space flight mission, ISRO will carry out two more unmanned missions and various other tests that included helicopter drop test and launch paid abort tests this year.
On the upcoming missions, Somanath said ISRO is planning about 12 to 14 missions in 2024 using all its three launch vehicles--PSLV, GSLV, and SSLV. This will include two commercial missions also.
Among the satellites to be launched included INSAT-3DS and the INDO-US collaboration satellite NISAR (NASA-ISRO Synthetic Aperture Radar) and a second-generation navigation satellite, using the Geosynchronous Satellite Launch Vehicle (GSLV).
After launching a remote sensing satellite using PSLV, the third flight of Small Satellite Launch Vehicle (SSLV) will also take place this year, he said, adding that the scramjet engine and the reusable launch vehicle tests will also be carried out in 2024.
IBNS
Senior Staff Reporter at Northeast Herald, covering news from Tripura and Northeast India.
Related Articles
India gears up for a global health showdown as 2nd WHO Traditional Medicine Summit Nears!
The Ministry of Ayush on Monday organized a Curtain Raiser Press Conference at the National Media Centre, New Delhi, ahead of the 2nd WHO Global Summit on Traditional Medicine, to be held from December 17–19 at Bharat Mandapam, New Delhi, where representatives of 100 countries are expected to attend.
Baldness battle may be over: New drug shows stunning results in phase III trial
Cosmo Pharmaceuticals N.V, an AI-powered healthcare and speciality pharma, has announced a compelling topline results from its two pivotal Phase III trials of clascoterone 5% topical solution for male androgenetic alopecia (AGA, also known as male-pattern hair loss), marking a potential first major therapeutic breakthrough in hair-loss treatment in more than three decades.
This everyday drink could slow ageing in severe mental illness, scientists reveal
New research conducted by King’s College London finds that coffee consumption within the NHS-recommended limit is linked to longer telomere lengths – a marker of biological ageing – among people with bipolar disorder and schizophrenia.
India’s solar explosion: 24.28 GW added this year — Clean energy hits unprecedented 31.25 GW!
Highlighting India’s historic clean energy expansion, Union Minister of New and Renewable Energy Pralhad Joshi said that India has recorded its highest-ever addition of non-fossil capacity in the current financial year at 31.25 GW, including 24.28 GW of solar.
Latest News
Team Mohta, Jalan enter Ruia Gold Cup final; Banerjee–Tolani win IMP Pair at Winter National Bridge meet
Canada creates new permanent residency pathway for 5000 foreign doctors
Congress suspends Navjot Kaur Sidhu over ‘Rs 500-crore suitcase’ remark, despite her clarification
Experts at ILO–NCAER roundtable stress gender-inclusive policies to unlock women’s potential in India's 'platform economy'
